It's a curious thing that investors' desire for short-term growth will often lead them to pay what looks like much too high a price for a company's long-term stream of cash flows. Although I wouldn't necessarily say that Becton Dickinson's (NYSE:BDX) current price is “much too high”, I do believe the stock is trading above its long-term fair value due to the fact that it's one of the few top-line growth stories in a very growth-challenged healthcare sector.
Please click below to continue:
http://www.investopedia.com/stock-analysis/050313/growthstarved-sector-becton-dickinson-rules-bdx-jnj-hsp-fms-mdt.aspx
Home
»
Becton Dickinson
»
Fresenius
»
Hospira
»
Investopedia
»
Johnson Johnson
»
Medtronic
» Investopedia: In A Growth-Starved Sector, Becton Dickinson Rules
Monday, May 6, 2013
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment